Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent [PDF]
Acimovic J +11 more
core +1 more source
Genotype-Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers. [PDF]
Etkins J +11 more
europepmc +1 more source
Toward a More accurate, Evidence-Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems. [PDF]
Backman JT.
europepmc +1 more source
Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. [PDF]
Dixon P +4 more
europepmc +1 more source
Voriconazole-induced Hypoglycemia in a Non-diabetic Patient: A Rare Cause. [PDF]
Patel GR, Singh V.
europepmc +1 more source
An Exploratory, Retrospective Study of the CYPRI Score for Pharmacogenetic Testing Among Mental Health Patients. [PDF]
Comtesse SM +3 more
europepmc +1 more source
Biological interactions of genotypes with , and in living donor liver transplantation recipients [PDF]
core +1 more source
Population Genetics of Pharmacogenetic Variants in a Greek Psychiatric Cohort of over 3000 Individuals. [PDF]
Ntoumou E +6 more
europepmc +1 more source
Exposure-Response Modeling and Simulation to Identify Optimal Mavacamten Posology When Coadministered with CYP3A4 and CYP2C19 Inhibitors in Patients with Obstructive HCM. [PDF]
Merali S +7 more
europepmc +1 more source
Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes [PDF]
Bloom, Adam Joseph +2 more
core +2 more sources

